Identification and interpretation of TET2 noncanonical splicing site intronic variants in myeloid neoplasm patients.

Das, Riku; Tu, Zheng Jin; Bosler, David S; Cheng, Yu-Wei

Das, Riku; Tu, Zheng Jin; Bosler, David S; Cheng, Yu-Wei.

Afiliação

Das R; Department of Laboratory Medicine, Robert J. Tomsich Pathology and Laboratory Medicine Institute Cleveland Clinic Cleveland Ohio USA.
Tu ZJ; Department of Laboratory Medicine, Robert J. Tomsich Pathology and Laboratory Medicine Institute Cleveland Clinic Cleveland Ohio USA.
Bosler DS; Department of Laboratory Medicine, Robert J. Tomsich Pathology and Laboratory Medicine Institute Cleveland Clinic Cleveland Ohio USA.
Cheng YW; Department of Laboratory Medicine, Robert J. Tomsich Pathology and Laboratory Medicine Institute Cleveland Clinic Cleveland Ohio USA.

EJHaem ; 4(3): 738-744, 2023 Aug.

Article em En | MEDLINE | ID: mdl-37601840

Palavras-chave

TET2; in silico prediction; myeloid neoplasm; nextgeneration sequencing (NGS); noncanonical splicing site; teneleven translocation 2; tumor suppressor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Revista: EJHaem Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google